Effects of Mitomycin C injected into the bronchial artery for pulmonary carcinomas were evaluated histologically.They consisted of 62 primary and 6 metastatic carcinomas, and were removed 1 to 30 days after treatment with 10 to 20 mg Mitomycin C.
Effects of the drug varied from area to area in a single tumor.It was more effective for poorly differentiated carcinomas and squamous cell carcinomas than for well differentiated adenocarcinomas.The difference was due partly to the difference in the sensitivity of the tumor cells to the drug, and partly to the difference in the blood supply of the tumors.Although most of the pulmonary carcinomas were believed to be supplied the blood by the bronchial artery, our study suggested strongly that some of the well differentiated adenocarcinoma, especially the areas with the bronchioloalveolar pattern, were nourished by the pulmonary arterial blood.Thus, they have not been effectively treated with the antitumor drug injected into the bronchial artery.
Three years survival rates appeared to have slightly increased in cases with squamous cell carcinoma and have been unchanged in cases with other types of pulmonary carcinomas, as compared with those with no adjuvant therapy.
Side effects (esophageal ulcer 1, esophagobronchial fistula 1, and cutaneous ulcers 2) were observed in 20 mg group.Focal interstitial fibrosis around the tumor was noted in a case treated twice, which was probably due to the opening of bronchopulmonary anastomosis.
View full abstract